Franklin M Berger

Director · 4 filings · Latest: Oct 13, 2026

Atea Pharmaceuticals, Inc.

Kezar Life Sciences, Inc.

Retension Pharmaceuticals, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
RTSN	Franklin M Berger	Director	Oct 13, 2026	Purchase	$12.00	10,000	$120.0K	10,000	Oct 13 10:10 PM
AVIR	Franklin M Berger	Director	Jun 18, 2026	Option Exercise	$0.00	29,600	—	536,097	Jun 23 9:00 PM
AVIR	Franklin Berger	—	Dec 10, 2024	Proposed Sale	$2.85	359,606	$1.0M	—	Dec 10 10:17 PM